Kirsten rat sarcoma viral oncogene homolog (KRAS) has been the most studied oncogene that has the highest mutation rate in the vast majority of tumour types, including PDAC (>90%) and CRC (~50%). This evidence concerns the gene KRAS and colorectal carcinoma.